These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1940960)

  • 1. Effects of CDP-choline on the recovery of patients with head injury.
    Calatayud Maldonado V; Calatayud Pérez JB; Aso Escario J
    J Neurol Sci; 1991 Jul; 103 Suppl():S15-8. PubMed ID: 1940960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
    Cho HJ; Kim YJ
    Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury.
    D'Orlando KJ; Sandage BW
    Neurol Res; 1995 Aug; 17(4):281-4. PubMed ID: 7477743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of postconcussional symptoms with CDP-choline.
    Levin HS
    J Neurol Sci; 1991 Jul; 103 Suppl():S39-42. PubMed ID: 1940965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citicoline for the Management of Patients with Traumatic Brain Injury in the Acute Phase: A Systematic Review and Meta-Analysis.
    Secades JJ; Trimmel H; Salazar B; González JA
    Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citicoline: pharmacological and clinical review, 2022 update.
    Secades JJ; Gareri P
    Rev Neurol; 2022 Nov; 75(s05):S1-S89. PubMed ID: 36544369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolome associated with severity of acute traumatic brain injury.
    Thomas I; Dickens AM; Posti JP; Czeiter E; Duberg D; Sinioja T; Kråkström M; Retel Helmrich IRA; Wang KKW; Maas AIR; Steyerberg EW; Menon DK; Tenovuo O; Hyötyläinen T; Büki A; Orešič M;
    Nat Commun; 2022 May; 13(1):2545. PubMed ID: 35538079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.
    Javaid S; Farooq T; Rehman Z; Afzal A; Ashraf W; Rasool MF; Alqahtani F; Alsanea S; Alasmari F; Alanazi MM; Alharbi M; Imran I
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Citicoline in the Management of Traumatic Brain Injury.
    Secades JJ
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33926011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness.
    Yu J; Meng F; He F; Chen F; Bao W; Yu Y; Zhou J; Gao J; Li J; Yao Y; Ge WP; Luo B
    Aging Dis; 2021 Apr; 12(2):386-403. PubMed ID: 33815872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.
    Trimmel H; Majdan M; Wodak A; Herzer G; Csomor D; Brazinova A
    Wien Klin Wochenschr; 2018 Jan; 130(1-2):37-44. PubMed ID: 28752349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is aura around citicoline fading? A systemic review.
    Agarwal S; Patel BM
    Indian J Pharmacol; 2017; 49(1):4-9. PubMed ID: 28458415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline for traumatic brain injury: a systematic review & meta-analysis.
    Meshkini A; Meshkini M; Sadeghi-Bazargani H
    J Inj Violence Res; 2017 Jan; 9(1):41-50. PubMed ID: 28039682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.
    El Sayed I; Zaki A; Fayed AM; Shehata GM; Abdelmonem S
    Neurosurg Rev; 2018 Apr; 41(2):427-438. PubMed ID: 27539610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies targeting lipid peroxidation in traumatic brain injury.
    Anthonymuthu TS; Kenny EM; Bayır H
    Brain Res; 2016 Jun; 1640(Pt A):57-76. PubMed ID: 26872597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards clinical management of traumatic brain injury: a review of models and mechanisms from a biomechanical perspective.
    Namjoshi DR; Good C; Cheng WH; Panenka W; Richards D; Cripton PA; Wellington CL
    Dis Model Mech; 2013 Nov; 6(6):1325-38. PubMed ID: 24046354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of post-traumatic cognitive impairments.
    Wortzel HS; Arciniegas DB
    Curr Treat Options Neurol; 2012 Oct; 14(5):493-508. PubMed ID: 22865461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.
    Bracken BK; Penetar DM; Rodolico J; Ryan ET; Lukas SE
    Pharmacol Biochem Behav; 2011 Jun; 98(4):518-24. PubMed ID: 21397626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The citicoline brain injury treatment (COBRIT) trial: design and methods.
    Zafonte R; Friedewald WT; Lee SM; Levin B; Diaz-Arrastia R; Ansel B; Eisenberg H; Timmons SD; Temkin N; Novack T; Ricker J; Merchant R; Jallo J
    J Neurotrauma; 2009 Dec; 26(12):2207-16. PubMed ID: 19803786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.